Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

(Reuters) - The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision.